Moreover, CD5 was not found to add any value in the distinction between thymomas and thymic carcinomas as all tumors that expressed CD5 in ≥50% of tumor cells also expressed CD117 in ≥10% of tumor cells. This evidence concerns the gene KIT and thymic carcinoma.